Essbio (ESSBIO-C) Stock Overview
Primarily engages in the provision of sanitation services in Chile. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 1/6 |
| Dividends | 3/6 |
ESSBIO-C Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Essbio S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CL$9.99 |
| 52 Week High | CL$13.00 |
| 52 Week Low | CL$9.00 |
| Beta | -0.085 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -31.53% |
| 3 Year Change | -14.69% |
| 5 Year Change | -15.91% |
| Change since IPO | -16.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| ESSBIO-C | CL Water Utilities | CL Market | |
|---|---|---|---|
| 7D | 0% | 0.1% | 0.1% |
| 1Y | -31.5% | 44.4% | 20.4% |
Return vs Industry: ESSBIO-C underperformed the CL Water Utilities industry which returned 44.4% over the past year.
Return vs Market: ESSBIO-C underperformed the CL Market which returned 20.4% over the past year.
Price Volatility
| ESSBIO-C volatility | |
|---|---|
| ESSBIO-C Average Weekly Movement | 0% |
| Water Utilities Industry Average Movement | 4.0% |
| Market Average Movement | 3.2% |
| 10% most volatile stocks in CL Market | 5.6% |
| 10% least volatile stocks in CL Market | 1.2% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine ESSBIO-C's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 1,247 | Cristian Vergara Castillo | www.essbio.cl |
Essbio S.A. primarily engages in the provision of sanitation services in Chile. It is involved in the construction and operation of public services for the production and distribution of drinking water; collection and disposal of wastewater; and treatment of liquid industrial waste. The company also provides laboratory services, chemical, biological, and other analysis.
Essbio S.A. Fundamentals Summary
| ESSBIO-C fundamental statistics | |
|---|---|
| Market cap | CL$264.21b |
| Earnings (TTM) | CL$33.05b |
| Revenue (TTM) | CL$255.89b |
Is ESSBIO-C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESSBIO-C income statement (TTM) | |
|---|---|
| Revenue | CL$255.89b |
| Cost of Revenue | CL$61.09b |
| Gross Profit | CL$194.80b |
| Other Expenses | CL$161.75b |
| Earnings | CL$33.05b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.25 |
| Gross Margin | 76.13% |
| Net Profit Margin | 12.92% |
| Debt/Equity Ratio | 154.6% |
How did ESSBIO-C perform over the long term?
See historical performance and comparisonDividends
Does ESSBIO-C pay a reliable dividends?
See ESSBIO-C dividend history and benchmarks| Essbio dividend dates | |
|---|---|
| Ex Dividend Date | May 25 2026 |
| Dividend Pay Date | May 28 2026 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 20 days |
Does ESSBIO-C pay a reliable dividends?
See ESSBIO-C dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/07 18:51 |
| End of Day Share Price | 2026/05/06 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Essbio S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.